Rocket Lab (RKLB) drew fresh attention after announcing its largest launch contract so far: a US$266 million multi launch agreement with the U.S. Space Force for at least 12 suborbital missions.

Even after the contract news, Rocket Lab’s share price is down 24% over the past 30 days and 16% year to date, yet its 1 year total shareholder return is 45.9% and the 3 year total shareholder return is very large. This suggests long term momentum has been strong even as shorter term sentiment has cooled.

If this kind of contract win has you looking beyond a single stock, it could be a good moment to see which other companies are trying to reshape space and defense technology through 34 robotics and automation stocks

The contract win and recent share price slide leave Rocket Lab trading well below both analyst targets and one fair value estimate. Is that discount justified by the risks, or does it point to mispriced upside potential for patient investors?

Most Popular Narrative: 24.9% Undervalued

The most followed valuation narrative on Rocket Lab pegs fair value at $85.04 per share, compared with the recent $63.89 close. This implies a sizeable discount and many expectations about what comes next.

Rocket Lab is mid transformation from a small-launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.

Curious what justifies that higher valuation band. The narrative focuses on rapid revenue expansion, rising margins and a future earnings profile that looks very different from today. The key is how those moving parts compound together.

Result: Fair Value of $85.04 (UNDERVALUED)

However, this Rocket Lab narrative still leans heavily on successful Neutron execution and timely delivery of large defense contracts, and setbacks on either front could quickly challenge the thesis.

Next Steps

With both enthusiasm and caution running through the Rocket Lab story, move quickly to review the full balance of potential upsides and red flags in the 2 key rewards and 3 important warning signs

Looking for more Rocket Lab investment ideas?

If you stop with Rocket Lab, you might miss other stocks that fit your style. Spend a few minutes with these screeners now so potential opportunities do not slip past.

• Target potential bargains before the crowd by scanning a focused list of 49 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio by reviewing solid balance sheet and fundamentals stocks screener (48 results).
• Get ahead of the market by checking a screener containing 20 high quality undiscovered gems that most investors are not watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.